pseudo-irreversible methyltransferase inh.

oral, phase I, cancer

from adenosine derivative library + opt.

Molecular Cancer Therapeutics

Janssen R&D

Chemical structure of molecule JNJ-64619178

The Janssen PRMT5 inhibitor, onametostat (JNJ-64619178) is a selective, orally active and pseudo-irreversible protein arginine methyltransferase 5 (PRMT5) inhibitor with high selectivity and potency (subnanomolar range, PRMT5-MEP-50 IC50=0.14 nM) under various…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: